A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in India and to Evaluate Perceptions and Practices of Physicians and Patients About Diabetes Management in India (DiabCare India 2011)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 12,000
- 试验地点
- 1
- 主要终点
- Mean duration of diabetes in type 2 patients
研究概览
简要总结
This study is conducted in Asia. The aim of this observational study is to evaluate the current status of diabetes management, control, and complications in diabetic subjects in India. Perceptions and practices of physicians and subjects about diabetes management will also be evaluated.
研究设计
- 研究类型
- Observational
- 观察模型
- Ecologic Or Community
- 时间视角
- Cross Sectional
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients should have visited the centre at least once in the last 3-6 months apart from the initial visit
- •First twenty patients of diabetes visiting the centre during the data collection period
- •Patients willing to sign the informed consent form
排除标准
- •Repetition of any patient as patients should not be included twice for any reason
- •Unwilling to participate or unable to comply with protocol requirements
结局指标
主要结局
Mean duration of diabetes in type 2 patients
时间窗: Evaluation visit
Mean age of onset of type 1 diabetes mellitus
时间窗: Evaluation visit
Mean age of onset of type 2 diabetes mellitus
时间窗: Evaluation visit
Percentage of patients on Insulin therapy
时间窗: Evaluation visit
Mean duration of diabetes in type 1 patients
时间窗: Evaluation visit
PPG (post prandial glucose)
时间窗: Evaluation visit
Percentage of patients archiving HbA1c target below or equal 7.0%
时间窗: Evaluation visit
Mean duration of treatment of type 2 diabetes mellitus
时间窗: Evaluation visit
HbA1c (Glycosylated Haemoglobin)
时间窗: Evaluation visit
Percentage of patients on Oral Anti-Diabetics Drug (OADs) therapy
时间窗: Evaluation visit
Mean FPG (fasting plasma glucose)
时间窗: Evaluation visit
Percentage of patients archiving HbA1c target below or equal 6.5%
时间窗: Evaluation visit
Percentage of patients having complications (dyslipidemia and hypertension, cardiovascular complications, peripheral vascular disease, diabetic nephropathy and diabetic eye complications)
时间窗: Evaluation visit
次要结局
未报告次要终点